findmyKOL
Clinical trialNCT03214874CompletedPhase 1Interventional

Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects

SponsorSarfez Pharmaceuticals, Inc.Enrollment24Chronic Kidney DiseasesCongestive Heart Failure
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India
  • I.E.C. Consultants

    Bangalore, India

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Jun 2017
Primary completion
20 Jul 2017
Completion
20 Jul 2017
Last update posted
18 Apr 2018
Registered enrollment
24
Registry id
NCT03214874

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.